Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.36 USD | +2.60% | +9.17% | -2.65% |
05-10 | HC Wainwright Adjusts Catalyst Pharmaceuticals' Price Target to $26 From $24, Keeps Buy Rating | MT |
05-09 | Transcript : Catalyst Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.65% | 1.88B | |
-2.35% | 89.08B | |
+2.76% | 40.9B | |
-13.06% | 32.25B | |
+54.69% | 25.14B | |
-16.49% | 15.39B | |
-8.73% | 11.91B | |
-42.60% | 11.89B | |
-12.82% | 11.64B | |
+7.34% | 9.03B |
- Stock Market
- Equities
- CPRX Stock
- News Catalyst Pharmaceuticals, Inc.
- HC Wainwright Raises Catalyst Pharmaceuticals' Price Target to $18 From $12, Keeps Buy Rating